MediPharm Labs Corp. (LABS.TO)
CAD 0.06
(-7.69%)
CAD 0.06
(-7.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 33.06 Million | 22.11 Million | 21.71 Million | 36.01 Million | 129.25 Million | 10.19 Million |
| Cost of Revenue | 27.2 Million | 24.03 Million | 36.95 Million | 79.99 Million | 86.33 Million | 6.23 Million |
| Gross Profit | 5.85 Million | -1.91 Million | -15.24 Million | -43.97 Million | 42.91 Million | 3.96 Million |
| Operating Expenses | 23.08 Million | 26.87 Million | 27.76 Million | 27.05 Million | 35.97 Million | 11.99 Million |
| Selling, General and Administrative Expenses | 24.79 Million | 24.75 Million | 23.03 Million | 28.95 Million | 34.18 Million | 6.81 Million |
| Research and Development Expenses | 209 Thousand | 1 Million | 1.35 Million | 2.22 Million | 867 Thousand | 261 Thousand |
| Other Expenses | - | 1.11 Million | 3.37 Million | -4.12 Million | 920 Thousand | 4.91 Million |
| Cost and Expenses | 51.31 Million | 50.9 Million | 64.72 Million | 107.04 Million | 122.31 Million | 18.22 Million |
| Operating Income | -18.25 Million | -29.53 Million | -48.91 Million | -72.57 Million | 6.93 Million | -8.02 Million |
| Interest Expense | 365 Thousand | 31 Thousand | 10.5 Million | 7.87 Million | 672 Thousand | 364 Thousand |
| Income Tax Expense | -276 Thousand | -6000.00 | 113 Thousand | -4.99 Million | 5.62 Million | -55 Thousand |
| Earnings before Tax | -13.35 Million | -29.98 Million | -54.68 Million | -72.1 Million | 6.75 Million | -8.46 Million |
| Net Income | -13.08 Million | -29.98 Million | -54.8 Million | -67.11 Million | 1.13 Million | -8.41 Million |
| Earnings Per Share Basic | -0.04 | -0.11 | -0.22 | -0.48 | 0.01 | -0.12 |
| Earnings Per Share Diluted | -0.04 | -0.11 | -0.22 | -0.48 | 0.01 | -0.12 |
| Weighted Average Shares Outstanding | 363.32 Million | 276.86 Million | 249.9 Million | 138.54 Million | 120 Million | 69.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 363.32 Million | 276.86 Million | 249.9 Million | 138.54 Million | 134.62 Million | 72.59 Million |
| Gross Margin | 0.18 | -0.09 | -0.70 | -1.22 | 0.33 | 0.39 |
| EBIT Margin | -0.32 | -1.15 | -1.71 | -1.66 | 0.08 | -0.70 |
| Profit Margin | -0.40 | -1.36 | -2.52 | -1.86 | 0.01 | -0.82 |
| EBITDA | -10.47 Million | -27.08 Million | -38.54 Million | -53.4 Million | 9.98 Million | -6.99 Million |
| Earnings Before Tax Margin | -0.55 | -1.34 | -2.25 | -2.02 | 0.05 | -0.79 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 10.35 Million | 9.77 Million | 9.13 Million | 33.06 Million | 8.5 Million | 9.58 Million |
| Cost of Revenue | 6.76 Million | 7.07 Million | 7.15 Million | 28.84 Million | 6.08 Million | 8.72 Million |
| Gross Profit | 3.58 Million | 2.69 Million | 1.97 Million | 4.21 Million | 2.41 Million | 855 Thousand |
| Operating Expenses | 5.95 Million | 6.54 Million | 5.32 Million | 23.08 Million | 6.77 Million | 8.48 Million |
| Selling, General and Administrative Expenses | 5.93 Million | 6.49 Million | 5.26 Million | - | 6.37 Million | 8.05 Million |
| Research and Development Expenses | 27 Thousand | 47 Thousand | 59 Thousand | - | 61 Thousand | 53 Thousand |
| Other Expenses | 33 Thousand | - | - | - | - | - |
| Cost and Expenses | 12.72 Million | 13.61 Million | 12.48 Million | 51.93 Million | 12.86 Million | 17.21 Million |
| Operating Income | -2.37 Million | -3.84 Million | -3.35 Million | -18.86 Million | -4.35 Million | -7.62 Million |
| Interest Expense | 210 Thousand | 110 Thousand | 101 Thousand | 365 Thousand | 149 Thousand | 110 Thousand |
| Income Tax Expense | - | 746.72 Thousand | -273 Thousand | -276 Thousand | -3000.00 | 110 Thousand |
| Earnings before Tax | -2.58 Million | -3.61 Million | -3.23 Million | -13.35 Million | -4.33 Million | -2.7 Million |
| Net Income | -2.58 Million | -3.61 Million | -2.96 Million | -13.08 Million | -4.32 Million | -2.7 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | - | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | - | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 404.78 Million | 403.68 Million | 401.39 Million | 363.32 Million | 399.57 Million | 397.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 404.78 Million | 403.68 Million | 401.39 Million | 363.32 Million | 399.57 Million | 397.47 Million |
| Gross Margin | 0.35 | 0.28 | 0.22 | 0.13 | 0.28 | 0.09 |
| EBIT Margin | -0.16 | -0.31 | -0.29 | - | -0.42 | -0.70 |
| Profit Margin | -0.25 | -0.37 | -0.32 | -0.40 | -0.51 | -0.28 |
| EBITDA | -1.63 Million | -3.05 Million | -2.63 Million | - | -3.56 Million | -6.74 Million |
| Earnings Before Tax Margin | -0.23 | -0.39 | -0.37 | -0.57 | -0.51 | -0.80 |
TBEV
MVP
002824
UPPR
TANA
600211